Michael Brinkenhoff

CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University.

Greater Baltimore Medical Center provides health care services. It is a nearly 310 bed hospital which also operates the Hospice of Baltimore, the Hospice of Howard County, the Gilchrist Center for Hospice Care, plus various clinics and medical offices. Greater Baltimore Medical Center was founded in 1960 and is headquartered in Baltimore, MD.